EMVISION MEDICAL DEVICES LTD - Announcements

3.63%

$2.00

Market Cap $169.7M

Technology Scientific & Technical Instruments

EMVision Medical Devices Limited is an Australian medical device company. The Company is... EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.More

Actinogen Medical (ASX:ACW) reaches 100th participant milestone in Alzheimer’s Disease Trial & confirms interim analysis timeline.

Announcements

Filter Results

All Price Sensitive Only

EMV	EMVision Go-To-Market Strategy Webinar		09:31	166.38KB	Share
EMV	Appendix 4G & Corporate Governance Statement		28/08/25	572.04KB	Share
EMV	Appendix 4E & Annual Report to 30 June 2025	PRICE SENSITIVE	28/08/25	1.56MB	Share
EMV	UCLA Health Activation & Continuous Innovation Study Update	PRICE SENSITIVE	26/08/25	325.25KB	Share
EMV	EMVision Awarded $3m Grant For Regional Benefits Study	PRICE SENSITIVE	15/08/25	203.53KB	Share
EMV	Notification regarding unquoted securities - EMV		11/08/25	22.4KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/07/25	290.37KB	Share
EMV	First Responder Program Advanced & Grant Milestone Achieved	PRICE SENSITIVE	29/07/25	415.53KB	Share
EMV	Key Developments in Pivotal Trial & Innovation Study	PRICE SENSITIVE	02/07/25	541.34KB	Share
EMV	EMVision Awarded $5m Non-Dilutive Government Grant	PRICE SENSITIVE	16/06/25	500.26KB	Share
EMV	Non-Executive Director Appointment		05/06/25	181.59KB	Share
EMV	Initial Director's Interest Notice		05/06/25	205.17KB	Share
EMV	Additional Pivotal Trial Site Activations	PRICE SENSITIVE	03/06/25	337.35KB	Share
EMV	Enhanced Algorithm Performance From Continuous Innovation	PRICE SENSITIVE	21/05/25	402.92KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/25	284.03KB	Share
EMV	Activation of Second US Pivotal Trial Site, Mayo Clinic	PRICE SENSITIVE	28/04/25	325.6KB	Share
EMV	Final Director's Interest Notice		16/04/25	245.25KB	Share
EMV	Non-Executive Director Retirement		16/04/25	179.41KB	Share
EMV	Emu Pivotal Validation Trial Commences	PRICE SENSITIVE	27/03/25	341.97KB	Share
EMV	Change of Share Registry Details		21/03/25	130.24KB	Share
EMV	First Responder Scanner in Successful Aeromedical Testing	PRICE SENSITIVE	19/03/25	448.9KB	Share
EMV	S&P DJI Announces March 2025 Quarterly Rebalance	PRICE SENSITIVE	07/03/25	174.42KB	Share
EMV	EMVision Releases its FY25 Half Yearly Report	PRICE SENSITIVE	27/02/25	145.95KB	Share
EMV	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/25	794.5KB	Share
EMV	US Ethics Approval Received for Pivotal Validation Trial	PRICE SENSITIVE	12/02/25	187.95KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/01/25	298.03KB	Share
EMV	EMVision Receives $2.12m R&D Tax Rebate	PRICE SENSITIVE	20/01/25	163.94KB	Share
EMV	Notification of cessation of securities - EMV		02/12/24	12.82KB	Share
EMV	Presentation - Ord Minnett Biotech & Medtech Conference		28/11/24	1.84MB	Share
EMV	Change of Director's Interest Notice		20/11/24	255.59KB	Share
EMV	Notification regarding unquoted securities - EMV		20/11/24	14.5KB	Share
EMV	Results of Annual General Meeting		15/11/24	159.07KB	Share
EMV	AGM Chair's Address & MD Presentation		14/11/24	1.61MB	Share
EMV	Algorithms Deliver Excellent Results In EMView Study	PRICE SENSITIVE	12/11/24	898.25KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/10/24	281.34KB	Share
EMV	EMV Prepares for Trial Following Positive FDA Engagement	PRICE SENSITIVE	29/10/24	237.55KB	Share
EMV	Notification of cessation of securities - EMV		25/10/24	13.32KB	Share
EMV	Notice of Annual General Meeting/Proxy Form		11/10/24	759.26KB	Share
EMV	Date of AGM & Closing Date for Director Nominations		18/09/24	122.39KB	Share
EMV	Becoming a substantial holder		10/09/24	233.95KB	Share
EMV	Cleansing Notice		10/09/24	219.27KB	Share
EMV	Ceasing to be a substantial holder		10/09/24	221.74KB	Share
EMV	Notification of cessation of securities - EMV		10/09/24	12.92KB	Share
EMV	Proposed issue of securities - EMV		10/09/24	17.54KB	Share
EMV	Notification regarding unquoted securities - EMV		10/09/24	22.07KB	Share
EMV	Application for quotation of securities - EMV		10/09/24	18.63KB	Share
EMV	Employee Incentive Plan Issues		10/09/24	320.48KB	Share
EMV	Appendix 4G & Corporate Governance Statement		28/08/24	491.18KB	Share
EMV	Appendix 4E & Annual Report to 30 June 2024	PRICE SENSITIVE	28/08/24	3.15MB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/07/24	283.43KB	Share
EMV	First Responder Device Unveiled	PRICE SENSITIVE	23/07/24	1.35MB	Share
EMV	Stage 3 Recuitment Achieved & FDA Engagement Underway	PRICE SENSITIVE	08/07/24	458.85KB	Share
EMV	Pilot Production Line Established & $1.25m Grant Received	PRICE SENSITIVE	24/06/24	279.53KB	Share
EMV	Trial data confirms early ischaemia detection capabilities	PRICE SENSITIVE	27/05/24	546.76KB	Share
EMV	Notification of cessation of securities - EMV		26/04/24	12.85KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	24/04/24	281.83KB	Share
EMV	Stage 2 Insights Confirm Diagnostic & Clinical Viability	PRICE SENSITIVE	27/03/24	503.12KB	Share
EMV	ASA Milestone Achieved for $0.6m Grant Payment	PRICE SENSITIVE	13/03/24	181.09KB	Share
EMV	Initial Director's Interest Notice		07/03/24	183.58KB	Share
EMV	Final Director's Interest Notice		07/03/24	243.33KB	Share
EMV	Board Changes		07/03/24	186.87KB	Share
EMV	Becoming a substantial holder		01/03/24	5.01MB	Share
EMV	Cleansing Notice		01/03/24	165.66KB	Share
EMV	Notification of cessation of securities - EMV		01/03/24	12.88KB	Share
EMV	Application for quotation of securities - EMV		01/03/24	18.54KB	Share
EMV	Application for quotation of securities - EMV		01/03/24	15.63KB	Share
EMV	CEO Half Yearly Update		29/02/24	276.79KB	Share
EMV	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/24	577.51KB	Share
EMV	Proposed issue of securities - EMV		29/02/24	14.77KB	Share
EMV	Strategic A$15.28M Investment from Keysight Technologies	PRICE SENSITIVE	29/02/24	241.94KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	279.2KB	Share
EMV	EMVision Receives $2.58m R&D Rebate & ASA Milestone Achieved	PRICE SENSITIVE	18/12/23	206.03KB	Share
EMV	Notification of cessation of securities - EMV		12/12/23	21.71KB	Share
EMV	Stage 2 Trial Recruitment Tartget Reached & EMU Unveiled	PRICE SENSITIVE	27/11/23	626.35KB	Share
EMV	Amended Constitution		21/11/23	555.23KB	Share
EMV	Results of Annual General Meeting		15/11/23	176.65KB	Share
EMV	AGM CEO Presentation including Latest Imaging Case Studies	PRICE SENSITIVE	15/11/23	925.63KB	Share
EMV	AGM Chairman's Address	PRICE SENSITIVE	15/11/23	185.54KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/23	279.77KB	Share
EMV	Notification regarding unquoted securities - EMV		26/10/23	26.5KB	Share
EMV	Gen 2 Advanced Prototype Assembled	PRICE SENSITIVE	24/10/23	368.06KB	Share
EMV	Notice of Annual General Meeting/Proxy Form		13/10/23	745.92KB	Share
EMV	Encouraging Interim Clinical Trial Results	PRICE SENSITIVE	10/10/23	301.22KB	Share
EMV	Change of Director's Interest Notice		29/09/23	260.27KB	Share
EMV	Notification of cessation of securities - EMV		29/09/23	21.71KB	Share
EMV	Date of AGM & Closing Date For Director Nominations		20/09/23	121.22KB	Share
EMV	ASX Small & Mid Cap Conference Investor Presentation		20/09/23	2.13MB	Share
EMV	Cleansing Notice		18/09/23	122.82KB	Share
EMV	Application for quotation of securities - EMV		18/09/23	25.34KB	Share
EMV	Notification regarding unquoted securities - EMV		18/09/23	27.63KB	Share
EMV	Employee Incentive Plan Issue		18/09/23	166.67KB	Share
EMV	Notification of cessation of securities - EMV		11/09/23	21.7KB	Share
EMV	Appendix 4G & Corporate Governance Statement		30/08/23	488.68KB	Share
EMV	Appendix 4E & Annual Report to 30 June 2023	PRICE SENSITIVE	30/08/23	2.65MB	Share
EMV	Latest Imaging and Clinical Trial Insights	PRICE SENSITIVE	22/08/23	439.6KB	Share
EMV	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/23	278.88KB	Share
EMV	Clinical Trial Progress & ASA Milestone Achieved	PRICE SENSITIVE	27/07/23	296.23KB	Share
EMV	Recruitment at Royal Melbourne Hospital Commences	PRICE SENSITIVE	29/06/23	163.91KB	Share
EMV	$1.75M Manufacturing Grant Payment Received	PRICE SENSITIVE	13/06/23	166.25KB	Share
EMV	Leadership Transition	PRICE SENSITIVE	31/05/23	174.93KB	Share

EMV EMVision Go-To-Market Strategy Webinar
09:31		166.38KB	Share
EMV Appendix 4G & Corporate Governance Statement
28/08/25		572.04KB	Share
EMV Appendix 4E & Annual Report to 30 June 2025
28/08/25	PRICE SENSITIVE	1.56MB	Share
EMV UCLA Health Activation & Continuous Innovation Study Update
26/08/25	PRICE SENSITIVE	325.25KB	Share
EMV EMVision Awarded $3m Grant For Regional Benefits Study
15/08/25	PRICE SENSITIVE	203.53KB	Share
EMV Notification regarding unquoted securities - EMV
11/08/25		22.4KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
30/07/25	PRICE SENSITIVE	290.37KB	Share
EMV First Responder Program Advanced & Grant Milestone Achieved
29/07/25	PRICE SENSITIVE	415.53KB	Share
EMV Key Developments in Pivotal Trial & Innovation Study
02/07/25	PRICE SENSITIVE	541.34KB	Share
EMV EMVision Awarded $5m Non-Dilutive Government Grant
16/06/25	PRICE SENSITIVE	500.26KB	Share
EMV Non-Executive Director Appointment
05/06/25		181.59KB	Share
EMV Initial Director's Interest Notice
05/06/25		205.17KB	Share
EMV Additional Pivotal Trial Site Activations
03/06/25	PRICE SENSITIVE	337.35KB	Share
EMV Enhanced Algorithm Performance From Continuous Innovation
21/05/25	PRICE SENSITIVE	402.92KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
30/04/25	PRICE SENSITIVE	284.03KB	Share
EMV Activation of Second US Pivotal Trial Site, Mayo Clinic
28/04/25	PRICE SENSITIVE	325.6KB	Share
EMV Final Director's Interest Notice
16/04/25		245.25KB	Share
EMV Non-Executive Director Retirement
16/04/25		179.41KB	Share
EMV Emu Pivotal Validation Trial Commences
27/03/25	PRICE SENSITIVE	341.97KB	Share
EMV Change of Share Registry Details
21/03/25		130.24KB	Share
EMV First Responder Scanner in Successful Aeromedical Testing
19/03/25	PRICE SENSITIVE	448.9KB	Share
EMV S&P DJI Announces March 2025 Quarterly Rebalance
07/03/25	PRICE SENSITIVE	174.42KB	Share
EMV EMVision Releases its FY25 Half Yearly Report
27/02/25	PRICE SENSITIVE	145.95KB	Share
EMV Half Yearly Report and Accounts
27/02/25	PRICE SENSITIVE	794.5KB	Share
EMV US Ethics Approval Received for Pivotal Validation Trial
12/02/25	PRICE SENSITIVE	187.95KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
28/01/25	PRICE SENSITIVE	298.03KB	Share
EMV EMVision Receives $2.12m R&D Tax Rebate
20/01/25	PRICE SENSITIVE	163.94KB	Share
EMV Notification of cessation of securities - EMV
02/12/24		12.82KB	Share
EMV Presentation - Ord Minnett Biotech & Medtech Conference
28/11/24		1.84MB	Share
EMV Change of Director's Interest Notice
20/11/24		255.59KB	Share
EMV Notification regarding unquoted securities - EMV
20/11/24		14.5KB	Share
EMV Results of Annual General Meeting
15/11/24		159.07KB	Share
EMV AGM Chair's Address & MD Presentation
14/11/24		1.61MB	Share
EMV Algorithms Deliver Excellent Results In EMView Study
12/11/24	PRICE SENSITIVE	898.25KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
30/10/24	PRICE SENSITIVE	281.34KB	Share
EMV EMV Prepares for Trial Following Positive FDA Engagement
29/10/24	PRICE SENSITIVE	237.55KB	Share
EMV Notification of cessation of securities - EMV
25/10/24		13.32KB	Share
EMV Notice of Annual General Meeting/Proxy Form
11/10/24		759.26KB	Share
EMV Date of AGM & Closing Date for Director Nominations
18/09/24		122.39KB	Share
EMV Becoming a substantial holder
10/09/24		233.95KB	Share
EMV Cleansing Notice
10/09/24		219.27KB	Share
EMV Ceasing to be a substantial holder
10/09/24		221.74KB	Share
EMV Notification of cessation of securities - EMV
10/09/24		12.92KB	Share
EMV Proposed issue of securities - EMV
10/09/24		17.54KB	Share
EMV Notification regarding unquoted securities - EMV
10/09/24		22.07KB	Share
EMV Application for quotation of securities - EMV
10/09/24		18.63KB	Share
EMV Employee Incentive Plan Issues
10/09/24		320.48KB	Share
EMV Appendix 4G & Corporate Governance Statement
28/08/24		491.18KB	Share
EMV Appendix 4E & Annual Report to 30 June 2024
28/08/24	PRICE SENSITIVE	3.15MB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
30/07/24	PRICE SENSITIVE	283.43KB	Share
EMV First Responder Device Unveiled
23/07/24	PRICE SENSITIVE	1.35MB	Share
EMV Stage 3 Recuitment Achieved & FDA Engagement Underway
08/07/24	PRICE SENSITIVE	458.85KB	Share
EMV Pilot Production Line Established & $1.25m Grant Received
24/06/24	PRICE SENSITIVE	279.53KB	Share
EMV Trial data confirms early ischaemia detection capabilities
27/05/24	PRICE SENSITIVE	546.76KB	Share
EMV Notification of cessation of securities - EMV
26/04/24		12.85KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
24/04/24	PRICE SENSITIVE	281.83KB	Share
EMV Stage 2 Insights Confirm Diagnostic & Clinical Viability
27/03/24	PRICE SENSITIVE	503.12KB	Share
EMV ASA Milestone Achieved for $0.6m Grant Payment
13/03/24	PRICE SENSITIVE	181.09KB	Share
EMV Initial Director's Interest Notice
07/03/24		183.58KB	Share
EMV Final Director's Interest Notice
07/03/24		243.33KB	Share
EMV Board Changes
07/03/24		186.87KB	Share
EMV Becoming a substantial holder
01/03/24		5.01MB	Share
EMV Cleansing Notice
01/03/24		165.66KB	Share
EMV Notification of cessation of securities - EMV
01/03/24		12.88KB	Share
EMV Application for quotation of securities - EMV
01/03/24		18.54KB	Share
EMV Application for quotation of securities - EMV
01/03/24		15.63KB	Share
EMV CEO Half Yearly Update
29/02/24		276.79KB	Share
EMV Half Yearly Report and Accounts
29/02/24	PRICE SENSITIVE	577.51KB	Share
EMV Proposed issue of securities - EMV
29/02/24		14.77KB	Share
EMV Strategic A$15.28M Investment from Keysight Technologies
29/02/24	PRICE SENSITIVE	241.94KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	279.2KB	Share
EMV EMVision Receives $2.58m R&D Rebate & ASA Milestone Achieved
18/12/23	PRICE SENSITIVE	206.03KB	Share
EMV Notification of cessation of securities - EMV
12/12/23		21.71KB	Share
EMV Stage 2 Trial Recruitment Tartget Reached & EMU Unveiled
27/11/23	PRICE SENSITIVE	626.35KB	Share
EMV Amended Constitution
21/11/23		555.23KB	Share
EMV Results of Annual General Meeting
15/11/23		176.65KB	Share
EMV AGM CEO Presentation including Latest Imaging Case Studies
15/11/23	PRICE SENSITIVE	925.63KB	Share
EMV AGM Chairman's Address
15/11/23	PRICE SENSITIVE	185.54KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23	PRICE SENSITIVE	279.77KB	Share
EMV Notification regarding unquoted securities - EMV
26/10/23		26.5KB	Share
EMV Gen 2 Advanced Prototype Assembled
24/10/23	PRICE SENSITIVE	368.06KB	Share
EMV Notice of Annual General Meeting/Proxy Form
13/10/23		745.92KB	Share
EMV Encouraging Interim Clinical Trial Results
10/10/23	PRICE SENSITIVE	301.22KB	Share
EMV Change of Director's Interest Notice
29/09/23		260.27KB	Share
EMV Notification of cessation of securities - EMV
29/09/23		21.71KB	Share
EMV Date of AGM & Closing Date For Director Nominations
20/09/23		121.22KB	Share
EMV ASX Small & Mid Cap Conference Investor Presentation
20/09/23		2.13MB	Share
EMV Cleansing Notice
18/09/23		122.82KB	Share
EMV Application for quotation of securities - EMV
18/09/23		25.34KB	Share
EMV Notification regarding unquoted securities - EMV
18/09/23		27.63KB	Share
EMV Employee Incentive Plan Issue
18/09/23		166.67KB	Share
EMV Notification of cessation of securities - EMV
11/09/23		21.7KB	Share
EMV Appendix 4G & Corporate Governance Statement
30/08/23		488.68KB	Share
EMV Appendix 4E & Annual Report to 30 June 2023
30/08/23	PRICE SENSITIVE	2.65MB	Share
EMV Latest Imaging and Clinical Trial Insights
22/08/23	PRICE SENSITIVE	439.6KB	Share
EMV Quarterly Activities/Appendix 4C Cash Flow Report
28/07/23	PRICE SENSITIVE	278.88KB	Share
EMV Clinical Trial Progress & ASA Milestone Achieved
27/07/23	PRICE SENSITIVE	296.23KB	Share
EMV Recruitment at Royal Melbourne Hospital Commences
29/06/23	PRICE SENSITIVE	163.91KB	Share
EMV $1.75M Manufacturing Grant Payment Received
13/06/23	PRICE SENSITIVE	166.25KB	Share
EMV Leadership Transition
31/05/23	PRICE SENSITIVE	174.93KB	Share

REFRESH

1 2 3

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.00		Change 0.070(3.63%)		Mkt cap ! $169.7M

Open	High	Low	Value	Volume
$1.92	$2.01	$1.92	$67.94K	34.31K

Buyers (Bids)

No.	Vol.	Price($)
3	6841	$1.98

Sellers (Offers)

Price($)	Vol.	No.
$2.00	1652	2

View Market Depth

No.	Vol.	Price($)
3	6841	1.975
3	10552	1.970
1	55	1.965
1	4000	1.960
1	55	1.955

Price($)	Vol.	No.
2.000	1652	2
2.010	5902	1
2.020	17522	2
2.040	1960	1
2.060	3136	1

Last trade - 15.07pm 05/09/2025 (20 minute delay)


Last $2.00		Change 0.070 ( 2.56 %)
Open	High	Low	Volume
$1.99	$2.00	$1.97	2813
Last updated 15.35pm 05/09/2025 ?

EMV (ASX) Chart

EMVISION MEDICAL DEVICES LTD - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories